Citadel Advisors’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-116,701
| Closed | -$589K | – | 7304 |
|
|
2022
Q1 | $589K | Buy |
+116,701
| New | +$589K | ﹤0.01% | 4281 |
|
|
2021
Q4 | – | Sell |
-1,967,118
| Closed | -$19.6M | – | 7498 |
|
|
2021
Q3 | $19.6M | Buy |
1,967,118
+251,202
| +15% | +$2.5M | ﹤0.01% | 921 |
|
|
2021
Q2 | $17M | Buy |
1,715,916
+1,000,021
| +140% | +$9.89M | ﹤0.01% | 1057 |
|
|
2021
Q1 | $6.87M | Buy |
+715,895
| New | +$6.87M | ﹤0.01% | 1763 |
|